44 startups found with PMF
The therapeutics category covers startups dedicated to drug discovery, development, and delivery systems that achieved significant market traction before the AI boom. These companies validated critical clinical pathways and patient needs, offering a blueprint for modern biotech innovation. By analyzing these proven models, founders can identify high-potential opportunities to integrate new technologies into established therapeutic frameworks.
AI drug discovery platform for neurotherapeutics
The AI-Native Operating System for Protein Engineering
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
Our drugs engage the immune system to fight tumors
Adventris makes cancer vaccines
High quality mRNA for therapeutic application
Enabling Tissue Targeting of Therapies
Empowering Mass Spec for Biotech and Beyond
Targeting the Tumor Ecosystem to address cancer drug resistance.